Renaissance Technologies’s Transmedics TMDX Stock Holding History

Renaissance Technologies’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,299	Closed	-$1.25M	–	3689
2025 Q4	$1.25M	Sell	10,299 -134,900	-93%	-$16.9M	﹤0.01%	2153
2025 Q3	$16.3M	Buy	+145,199	New	+$17M	0.02%	834
2024 Q4	–	Sell	-111,799	Closed	-$17.6M	–	3915
2024 Q3	$17.6M	Sell	111,799 -20,100	-15%	-$3.1M	0.03%	742
2024 Q2	$19.9M	Buy	131,899 +68,100	+107%	+$8.17M	0.03%	589
2024 Q1	$4.72M	Buy	63,799 +52,100	+445%	+$4.29M	0.01%	1445
2023 Q4	$923K	Sell	11,699 -13,600	-54%	-$820K	﹤0.01%	2458
2023 Q3	$1.39M	Sell	25,299 -47,500	-65%	-$3.42M	﹤0.01%	2093
2023 Q2	$6.11M	Buy	72,799 +9,600	+15%	+$735K	0.01%	1311
2023 Q1	$4.79M	Buy	+63,199	New	+$4.37M	0.01%	1501
2022 Q4	–	Sell	-102,999	Closed	-$4.3M	–	4417
2022 Q3	$4.3M	Buy	+102,999	New	+$4.48M	0.01%	1529

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's TMDX Position: Q1 2026 in Review

Renaissance Technologies sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 10,299 shares — an estimated $1.25M sold.

Renaissance Technologies first reported a position in TMDX in Q3 2022 and held it in 10 quarters. The position peaked at $19.9M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Renaissance Technologies reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Renaissance Technologies sold 10,299 Transmedics shares in Q1 2026, an estimated $1.25M.
Renaissance Technologies first reported a position in Transmedics in Q3 2022 and held it in 10 quarters.
Renaissance Technologies's Transmedics position peaked at $19.9M in Q2 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.